About Us Contact Us Disclaimer Sitemap
  New Old
HOME TRADING DERIVATIVES PMS MUTUAL FUNDS IPO BONDS RESEARCH MARKET
left «« +1 «« -1 right
 
  Equity Analysis
  Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
  Volume
  Analysis
  News Analysis
Corporate Action
  Corporate Info
  Other Market
 
Company News  
 
Sun Pharmaceutical Industries Ltd.
Change Company   
BSE Code 524715
ISIN Demat INE044A01036
Book Value(Rs.) 98.39
NSE Code SUNPHARMA
Dividend Yield % 0.66
Market Cap(Rs. in millions) 1001242.48
P/E 112.96
EPS 3.69
Face Value(Rs.) 1  
19-Aug-2019 Announcement under Regulation 30 (LODR)-Press Re...
17-Aug-2019 Sun Pharma, CMS ink licensing agreement for gener...
14-Aug-2019 Sun Pharma enters into licensing agreement with C...
14-Aug-2019 CONCOR, Infosys and Wipro to see some action today
13-Aug-2019 Sun Pharma reports 31% rise in Q1 consolidated ne...
06-Aug-2019 Clarification / Confirmation On News Item
03-Aug-2019 Sun Pharma discontinues operations at two clinica...
01-Aug-2019 Sun Pharma aims 'low-to-mid teens' growth in cons...
01-Aug-2019 Sun Pharma files application for Tildrakizumab in...
01-Aug-2019 Sun Pharmaceutical Industries submits press relea...
01-Aug-2019 ZEEL, Sun Pharma and APSEZ to see some action tod...
01-Aug-2019 Announcement under Regulation 30 (LODR)-Press Re...
26-Jul-2019 Notice Of Book Closure And Details Of 27Th Annua...
22-Jul-2019 Shareholding for the Period Ended June 30, 2019
15-Jul-2019 Announcement under Regulation 30 (LODR)-Press Re...
Page 1 of 6
Prev || Next
 
Terms & Conditions Copyright ©ATLAS All rights reserved. Designed || Developed & Content Powered By Accord Fintech Pvt.Ltd.

Important Links : SEBI | NSE | BSE | RBI | CDSL | NSDL | Investor Grievance| Policy
SEBI REG. NO. NSE : CASH INB230956935; FO INF230956935; CURRENCY INE230956935 | BSE : CASH INB010956937; FO INF010956937
PMS : INP000000530 | AMFI : ARN0770 | CDSL : IN-DP-CDSL-465-2008